FTC focus on monitoring pharmas ‘reverse payment agreement’

Published: 2017-01-09 13:33:16

Updated: 2017-01-09 13:33:16

The Fair Trade Commission(FTC) showed the 2017 business plan and announced to focus on pharmaceutical companies’ reverse payment agreements.

The FTC criticized the pharmaceutical field’s enforcement(March 15 2015) of the Patent Linkage System has caused reverse payment agreements which increase pressure of drug price for people in Korea.

Reverse payment agreement is price fixing which a paten...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.